Copyright
©The Author(s) 2022.
World J Gastroenterol. Oct 21, 2022; 28(39): 5764-5783
Published online Oct 21, 2022. doi: 10.3748/wjg.v28.i39.5764
Published online Oct 21, 2022. doi: 10.3748/wjg.v28.i39.5764
Table 6 Area under the curve, sensitivity and specificity of difference bile acids, conventional biochemical indicators in primary biliary cirrhosis, autoimmune hepatitis and control group
AUC | Sensitivity | Specificity | |
LCA | 0.68 | 0.82 | 0.50 |
LCA + TLCA | 0.73 | 0.74 | 0.46 |
CDCA | 0.74 | 0.74 | 0.54 |
AST | 0.54 | 0.67 | 0.58 |
ALT | 0.61 | 0.64 | 0.61 |
ALP | 0.41 | 0.56 | 0.35 |
GGT | 0.43 | 0.50 | 0.46 |
TBiL | 0.53 | 0.59 | 0.42 |
DBiL | 0.47 | 0.44 | 0.62 |
TBA | 0.52 | 0.52 | 0.42 |
- Citation: Ma ZH, Wang XM, Wu RH, Hao DL, Sun LC, Li P, Niu JQ. Serum metabolic profiling of targeted bile acids reveals potentially novel biomarkers for primary biliary cholangitis and autoimmune hepatitis. World J Gastroenterol 2022; 28(39): 5764-5783
- URL: https://www.wjgnet.com/1007-9327/full/v28/i39/5764.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i39.5764